The effect of pegylated granulocyte colony-stimulating factor on collateral function and myocardial ischaemia in chronic coronary artery disease: A randomized controlled trial.

Tobias TraupeMichael StollerSteffen GloeklerPascal MeierChristian Seiler

Published in: European journal of clinical investigation (2018)

Pegfilgrastim given over the course of 6 months improves collateral function in chronic stable CAD, which is reflected by reduced myocardial ischaemia during a controlled coronary occlusion.

Keyphrases

coronary artery disease
left ventricular
percutaneous coronary intervention
coronary artery bypass grafting
cardiovascular events
coronary artery
cardiovascular disease
aortic stenosis
recombinant human
acute coronary syndrome